List of Tables
Table 1. Global ERA Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global ERA Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global ERA Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global ERA Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global ERA Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global ERA Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global ERA Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market ERA Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of ERA Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of ERA Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of ERA Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of ERA Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global ERA Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on ERA Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global ERA Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global ERA Drugs Sales by Region (K Units), 2021–2026
Table 18. Global ERA Drugs Sales Market Share by Region (2021–2026)
Table 19. Global ERA Drugs Sales by Region (K Units), 2027–2032
Table 20. Global ERA Drugs Sales Market Share by Region (2027–2032)
Table 21. Global ERA Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global ERA Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global ERA Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global ERA Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America ERA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America ERA Drugs Sales by Country (K Units), 2021–2026
Table 27. North America ERA Drugs Sales by Country (K Units), 2027–2032
Table 28. North America ERA Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America ERA Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe ERA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe ERA Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe ERA Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe ERA Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe ERA Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific ERA Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific ERA Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific ERA Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific ERA Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific ERA Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America ERA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America ERA Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America ERA Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America ERA Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America ERA Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa ERA Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa ERA Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa ERA Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa ERA Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa ERA Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global ERA Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global ERA Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global ERA Drugs Sales Market Share by Type (2021–2026)
Table 53. Global ERA Drugs Sales Market Share by Type (2027–2032)
Table 54. Global ERA Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global ERA Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global ERA Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global ERA Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global ERA Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global ERA Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global ERA Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global ERA Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global ERA Drugs Sales Market Share by Application (2021–2026)
Table 63. Global ERA Drugs Sales Market Share by Application (2027–2032)
Table 64. Global ERA Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global ERA Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global ERA Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global ERA Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global ERA Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global ERA Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Johnson & Johnson ERA Drugs Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Zhengda Tianqing Company Information
Table 76. Zhengda Tianqing Description and Business Overview
Table 77. Zhengda Tianqing ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Zhengda Tianqing ERA Drugs Product
Table 79. Zhengda Tianqing Recent Developments/Updates
Table 80. Sinotherapeutics Company Information
Table 81. Sinotherapeutics Description and Business Overview
Table 82. Sinotherapeutics ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Sinotherapeutics ERA Drugs Product
Table 84. Sinotherapeutics Recent Developments/Updates
Table 85. Qilu Pharmaceutical Company Information
Table 86. Qilu Pharmaceutical Description and Business Overview
Table 87. Qilu Pharmaceutical ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Qilu Pharmaceutical ERA Drugs Product
Table 89. Qilu Pharmaceutical Recent Developments/Updates
Table 90. Hangzhou Zhongmei Huadong Pharmaceutical Company Information
Table 91. Hangzhou Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 92. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs Product
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 95. Shanghai Xudong Haipu Pharmaceutical Company Information
Table 96. Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
Table 97. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Shanghai Xudong Haipu Pharmaceutical ERA Drugs Product
Table 99. Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
Table 100. Shanghai Pharmaceutical Group Company Information
Table 101. Shanghai Pharmaceutical Group Description and Business Overview
Table 102. Shanghai Pharmaceutical Group ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Pharmaceutical Group ERA Drugs Product
Table 104. Shanghai Pharmaceutical Group Recent Developments/Updates
Table 105. Jiangsu Yunyang Group Pharmaceutical Company Information
Table 106. Jiangsu Yunyang Group Pharmaceutical Description and Business Overview
Table 107. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jiangsu Yunyang Group Pharmaceutical ERA Drugs Product
Table 109. Jiangsu Yunyang Group Pharmaceutical Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Mylan ERA Drugs Product
Table 114. Mylan Recent Developments/Updates
Table 115. Teva Company Information
Table 116. Teva Description and Business Overview
Table 117. Teva ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teva ERA Drugs Product
Table 119. Teva Recent Developments/Updates
Table 120. Dr. Reddy's Laboratories Company Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Dr. Reddy's Laboratories ERA Drugs Product
Table 124. Dr. Reddy's Laboratories Recent Developments/Updates
Table 125. Gilead Sciences Company Information
Table 126. Gilead Sciences Description and Business Overview
Table 127. Gilead Sciences ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Gilead Sciences ERA Drugs Product
Table 129. Gilead Sciences Recent Developments/Updates
Table 130. United Therapeutics Company Information
Table 131. United Therapeutics Description and Business Overview
Table 132. United Therapeutics ERA Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. United Therapeutics ERA Drugs Product
Table 134. United Therapeutics Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. ERA Drugs Distributors List
Table 138. ERA Drugs Customers List
Table 139. ERA Drugs Market Trends
Table 140. ERA Drugs Market Drivers
Table 141. ERA Drugs Market Challenges
Table 142. ERA Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of ERA Drugs
Figure 2. Global ERA Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global ERA Drugs Market Share by Type: 2025 & 2032
Figure 4. Bosentan Product Picture
Figure 5. Ambrisentan Product Picture
Figure 6. Macitentan Product Picture
Figure 7. Global ERA Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global ERA Drugs Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global ERA Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global ERA Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global ERA Drugs Sales (K Units), 2021–2032
Figure 15. Global ERA Drugs Average Price (US$/Unit), 2021–2032
Figure 16. ERA Drugs Report Years Considered
Figure 17. ERA Drugs Sales Share by Manufacturers in 2025
Figure 18. Global ERA Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global ERA Drugs Players: Market Share by Revenue in ERA Drugs in 2025
Figure 20. ERA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global ERA Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America ERA Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America ERA Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe ERA Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe ERA Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific ERA Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific ERA Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America ERA Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America ERA Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa ERA Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa ERA Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE ERA Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of ERA Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of ERA Drugs by Type (2021–2032)
Figure 55. Global ERA Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of ERA Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of ERA Drugs by Application (2021–2032)
Figure 58. Global ERA Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. ERA Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
